![Dave Kuo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dave Kuo
Human Resources Officer at PARDES BIOSCIENCES, INC.
Dave Kuo active positions
Companies | Position | Start | End |
---|---|---|---|
PARDES BIOSCIENCES, INC. | Human Resources Officer | - | - |
Career history of Dave Kuo
Former positions of Dave Kuo
Companies | Position | Start | End |
---|---|---|---|
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Chief Tech/Sci/R&D Officer | - | 2016-12-14 |
Human Resources Officer | - | 2016-12-14 |
Training of Dave Kuo
University of California | Undergraduate Degree |
Statistics
International
United States | 4 |
Operational
Human Resources Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Pardes Biosciences, Inc.
![]() Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA. | Health Technology |
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
- Stock Market
- Insiders
- Dave Kuo
- Experience